A new type of polymer gel dosimeter, which responds well to absorbed dose even when manufactured in the presence of normal levels of oxygen, was recently described by Fong et al. ͓Phys. Med. Biol. 46, 3105-3113 ͑2001͔͒ and referred to by the acronym MAGIC. The aim of this study was to investigate the feasibility of using this new type of gel for intensity-modulated radiation therapy ͑IMRT͒ verification. Gel manufacturing was carried out in room atmosphere under normal levels of oxygen. IMRT inverse treatment planning was performed using the Helios software. The gel was irradiated using a linear accelerator equipped with a dynamic multileaf collimator, and intensity modulation was achieved using sliding window technique. The response to absorbed dose was evaluated using magnetic resonance imaging. Measured and calculated dose distributions were compared with regard to in-plane isodoses and dose volume histograms. In addition, the spatial and dosimetric accuracy was evaluated using the gamma formalism. Good agreement between calculated and measured data was obtained. In the isocenter plane, the 70% and 90% isodoses acquired using the different methods are mostly within 2 mm, with up to 3 mm disagreement at isolated points. For the planning target volume ͑PTV͒, the calculated mean relative dose was 96.8Ϯ2.5% ͑1 SD͒ and the measured relative mean dose was 98.6Ϯ2.2%. Corresponding data for an organ at risk was 34.4Ϯ0.9% and 32.7Ϯ0.7%, respectively. The gamma criterion ͑3 mm spatial/3% dose deviation͒ was fulfilled for 94% of the pixels in the target region. Discrepancies were found in hot spots the upper and lower parts of the PTV, where the measured dose was up to 11% higher than calculated. This was attributed to sub optimal scatter kernels used in the treatment planning system dose calculations. Our results indicate great potential for IMRT verification using MAGIC-type polymer gel.
I. INTRODUCTION
In recent years there has been a fast development of techniques used for the planning and delivery of radiation therapy. The common goal is to achieve higher conformity around the tumor volume, i.e., to be able to irradiate the tumor to a high absorbed dose without damaging the surrounding healthy tissue. A technique that has attracted especially much interest is intensity-modulated radiation therapy ͑IMRT͒. Using conventional conformal techniques, each beam portal is shaped to conform to the projected shape of the planning target volume ͑PTV͒. In order to further conform the dose distribution, IMRT also allows for varying intensities for separate beamlets within a beam portal. The intensity modulation can be generated using different techniques, of which the most commonly used are multiple-static multileaf collimator ͑MLC͒-shaped fields ͑''step and shoot''͒ or dynamic MLC techniques ͑DMLC, ''sliding window''͒. 1 In 1997, Webb 2 stated that a hindrance to the introduction of IMRT is the problem of verifying its accuracy. A number of different approaches were suggested, e.g., verification of the mechanical movements of the MLCs, electronic portal imaging, in vivo dosimetry or experiments with phantoms.
Besides the fact that a full understanding of all three dimensional conformal radiotherapy generated dose distributions requires volumetric verification, the verification of IMRT is further complicated by the fact that the radiation field is continuously changing size and shape ͑sliding window͒ or made up by multiple small beam segments ͑step and shoot͒. Thus, a detector with the possibility for integrating volumetric measurements is needed. Since an IMRT dose distribution often contains sharp dose gradients, good spatial resolution as well as independence of dose rate is desirable. Another crucial feature is that the detector response should be independent of incident radiation direction. This would enable a complete treatment to be evaluated in a single measurement, as opposed to measuring each beam separately.
No dosimetric system conventionally used in external radiotherapy, such as ion chambers, diodes, thermoluminiscent dosimeters or film can fulfill all above requirements. First, volumetric measurements are not feasible without multiple detectors and/or repeated measurements. In the case of ion chambers, the sensitive volume is often considered too large to obtain sufficient spatial resolution. Film can be stacked in a pile for 3D measurements, but suffers from lack of tissue equivalence and exhibits dependence on angular distribution of the radiation. 3 A method that has previously been suggested for phantom verification of IMRT is polymer gel dosimetry. 4 -6 The gel dosimeter has potential for volumetric measurements with sub-mm spatial resolution, 7 is soft-tissue equivalent, 8 and independent of incident radiation direction. 9 A major impediment to the introduction of gel dosimetry as a clinical tool has been that it is a rather complicated system in terms of the experimental handling. For example, great care has to be taken to exclude all oxygen when manufacturing Bang-type polymer gels, since free radical scavengers ͑such as, e.g., oxygen͒ inhibit polymerization. Consequently, gels have to be prepared in a sealed system, and a phantom material that is nonpermeable to oxygen must be used. A new gel composition, which responds well to absorbed dose even when manufactured in the presence of normal levels of oxygen ͑acronym MAGIC, Methacrylic and Ascorbic acid in Gelatin Initiated by Copper͒, was recently presented. 10 The purpose of this study was to investigate the feasibility of using MAGIC-type polymer gel for IMRT verification. The response to absorbed dose was evaluated using magnetic resonance imaging ͑MRI͒. Relative evaluations were performed. Measured dose distribution data was compared with treatment planning system ͑TPS͒ calculations with regard to in-plane isodoses and dose volume histograms. In addition, the spatial and dosimetric accuracy was evaluated using the gamma formalism. 11 In order to investigate the temporal behavior of the system, MRI was performed at two occasions, 2 days and 2 weeks post irradiation. Furthermore, the uncertainty of the present system was evaluated.
II. METHODS AND MATERIAL

A. Gel manufacturing
Since the dose response of the gel used in this study is not negatively affected by oxygen contamination, manufacturing was performed in room atmosphere, under normal levels of oxygen. However, many of the ingredients used are toxic, and thus the gel was handled in a fume cupboard during preparation. The composition of the gel was the same as in a previous study by our group. 12 A volume of 1700 ml of gel was manufactured using methacrylic acid ͑purity grade approximately 99%, Sigma Aldrich͒, gelatin ͑swine skin, 300 Bloom, Sigma Aldrich͒, ascorbic acid ͑minimum 99%, Sigma Aldrich͒, copper sulfate ͑pentahydrate, 98ϩ%, Sigma Aldrich͒ and ultra pure deionized water ͑Table I͒. Gelatin was added to the room tempered water, which was then heated to 45°C. The mixture was kept at this temperature until the gelatin had completely melted after approximately 30 minutes. The heat was then turned off and when the mixture had cooled to 35°C, the ascorbic acid and copper sulfate were added. After another few minutes the methacrylic acid was added. The solution was stirred continuously during the entire mixing procedure.
Approximately 1500 ml of the gel was poured into a cylindrical glass flask with height 17 cm and diameter 11 cm ͑hereafter referred to as the IMRT phantom͒. The relatively large volume of the flask was chosen not to limit the size of the target and thus make it clinically relevant. On the other hand, the phantom had to be small enough to fit into the head coil of the MR scanner, since a lower signal to noise ratio would be obtained with the body coil. Thus, the size of the flask was a compromise between these two. Twelve 10 ml screw-top glass vials to be used for dose response evaluation were also filled with gel.
If the gels are allowed to set in a refrigerator, a few hours are sufficient for complete gelation. However, for practical reasons, the gel phantoms were left in the refrigerator over night.
B. Treatment planning and irradiation
Inverse treatment planning was performed using the Helios software ͑Varian Medical Systems, Palo Alto, CA͒. A kidney-shaped target was defined and an intensity modulated treatment plan with seven coplanar beams was generated using the TPS ͓Fig. 1͑a͔͒. The PTV was planned to receive 16.5 Gy at the normalization point, with minimum and maximum allowed dose 15.3 Gy and 17.7 Gy, respectively ͑pri-ority 90͒. The corresponding values for an organ at risk ͑OAR͒ defined adjacent to the PTV ͓Fig. 1͑b͔͒, was 0 Gy ͑priority 0͒ and 7.1 Gy ͑priority 50͒. The plan was based on CT scans of the phantom, for this purpose filled with water. Since the gel is nearly water equivalent, 10 this is assumed not to have any significant effect on the absorbed dose calculations. Scans covering the entire phantom were acquired in 3 mm slices.
The gels were irradiated the day after preparation using a Varian 2300 C/D linear accelerator ͑Varian Medical systems, Palo Alto, CA͒ and 6 MV photons. The accelerator was equipped with a 120 leaf dynamic MLC and intensity modulation was achieved using the sliding window technique.
Irradiation of the IMRT phantom was performed according to the treatment plan. The vials used for dose response evaluation were placed at maximum dose depth in a water bath, and irradiated to absorbed doses between 1 Gy and 30 Gy. One sample was left unirradiated.
After irradiation the gels were stored in a refrigerator. They were placed in the MRI room on the morning of scanning ͑approximately 10 hours before the measurements started͒, in order to establish thermal equilibrium. 13 
C. MR imaging
MR imaging was performed 2 days post irradiation using a 1.5 T Siemens Vision scanner ͑Siemens, Erlangen, Germany͒, with a 32-echo multiple spin-echo pulse sequence ͑Table II͒. The IMRT phantom was placed in the center of the head coil. The dose response vials were attached to the phantom within the field of view, and thus imaged at the same time. In order for direct comparison between gel measured and TPS calculated data to be feasible, 3 mm thick slices were acquired at the same positions as the CT slices. Twelve slices were needed to cover the PTV. To avoid crosstalk the slices were separated by a 3 mm distance, i.e., adjacent slices were not scanned at the same run of the sequence. Therefore, the sequence was repeated three times, with four slices acquired from each measurement. The total acquisition time was approximately 1.5 hours. In order to investigate the temporal stability of the system, MRI was repeated 2 weeks post irradiation. Between the two imaging sessions both the IMRT phantom and the dose response vials were stored in a refrigerator.
D. Image and data processing
The T2 value of each pixel was derived by fitting a monoexponential decay to the MR signal values using the Levenberg-Marquardt optimization algorithm.
14 The calculations were performed using a routine written in IDL ͑Inter-active Data Language, Research Systems Inc., Boulder, CO, USA͒.
Background subtraction of the R2 images as well as matching and normalization of calculated and gel measured images were performed using the in-house developed software PMRelax v5.0. 15 The TPS and MR images were matched using the well perceptible glass wall of the phantom as reference. The value in a region well away from the PTV was taken as background value. According to the treatment plan the relative absorbed dose in this region was less than 1% of the normalization dose. Normalization of the measured and calculated dose distributions was performed in the isocenter plane, using a region of 9 pixels. After application of a median filter ͑kernel 5ϫ5), isodoses were calculated using IDL.
A quantitative comparison of measured and calculated data was obtained using the gamma technique developed by Low et al. 11 The gamma routine was run under MATLAB ͑The MathWorks, Inc., Natick, USA͒. Dose difference for corresponding points and distance-to-agreement in the investigated distributions was determined, and a gamma index was calculated based on the result. If the deviation is within the maximum allowed limits ͑maximum distance-toagreement and/or dose difference͒ determined by the user, the calculated index will be lower than unity. In the routine developed by Low et al. one of the investigated distributions is chosen as a reference. However, since the aim of the present study was to investigate the feasibility of the proposed method, neither the measured nor the calculated distribution was assumed to be correct. Therefore, gamma indexes were calculated using both distributions as reference, and the resulting gamma maps were added. The gamma analysis was conducted for inter-slice dose distribution comparisons. A unique feature of gel dosimetry is the possibility for true three-dimensional ͑3D͒ evaluation using dose volume histograms ͑DVH͒. DVHs were calculated both for the PTV and the OAR.
E. Evaluation of standard uncertainty in relative absorbed dose measurements
The uncertainty in the determination of relative absorbed dose was estimated following the general guidelines given by the International Organization for Standardization ͑ISO͒. 16 Standard uncertainties are classified into type A and type B. Type A uncertainties are related to the distribution of the measured values around the mean, and type B uncertainties are such that cannot be estimated by repeated measurements. For gel dosimetry and MRI several such sources of uncertainty must be considered; varying accelerator output during irradiation, temperature drift in the phantom during measurement and nonuniformity of the radio frequency ͑RF͒ field in the MR scanner ͑leading to signal variation at different positions in the gel phantom͒. In the case of relative measurements a linear relation between R2 and absorbed dose is assumed, which is only true to a certain extent, 17 introducing additional uncertainty.
Furthermore, when comparing gel measured dose distributions with corresponding data obtained using other methods ͑in this case TPS calculations͒ large uncertainties are often introduced by image and data processing, i.e., background subtraction, normalization and image matching.
The uncertainty estimation was performed for regions of high dose ͑i.e., the PTV͒, and larger relative uncertainties can be expected for areas of low dose.
Evaluation of type A standard uncertainty
The R2 standard deviation in a vial irradiated to an absorbed dose corresponding to the target dose was taken as the type A standard uncertainty. The standard deviation was obtained in a region of interest covering the vial ͑144 pixels͒.
Evaluation of type B standard uncertainty
Assumed that the type B uncertainties have an approximately Gaussian distribution, the type B standard uncertainty can be calculated as
where L is the estimated limit of the distribution and c is a factor corresponding to the confidence level. According to the IAEA, cϭ2 should be chosen if the experimenter is fairly sure and cϭ3 if the experimenter is almost certain of the estimated limits ϮL.
De Deene and De Wagter have investigated the effect on the measured T2 value from heating of BANG-type gel during MR scanning, caused by absorption of RF power. 19 Under the assumption that this effect is not much influenced by the composition of the gel, their results were used to estimate the uncertainty contribution from this source. In this study, considering the gel volume of 1.5 liters and scanning time of 1.5 h as well as cooling from conduction and thermal radiation, a negligible temperature rise was expected. Consequently, this source of uncertainty was disregarded.
An investigation of the RF field nonuniformity was conducted using a homogenous gel consisting of water, gelatin and copper sulfate, contained in the same type of glass flask as used for the IMRT phantom. The amount of copper sulfate added to the gel was adjusted so that the resulting T2 values would be of the same magnitude as that of a gel irradiated to a high absorbed dose. The gel was not irradiated. During MR scanning, the phantom was placed at the same position in the head coil as the IMRT phantom. The uncertainty limits were taken as the maximum relative difference in T2 over the region in the homogenous phantom corresponding to the irradiated region in the IMRT phantom.
Several groups have investigated the effect of the uncertainty in the calibration curve on the relative dose uncertainty. [20] [21] [22] Baldock et al. and Low et al. concluded that the overall uncertainty is dominated by the R2 voxel-tovoxel standard deviation ͑in this study taken as the type A standard uncertainty͒. Thus other contributions from the uncertainty in the calibration curve fit were not considered here.
In the case of uncertainty related to image and data processing, L was estimated as the maximum difference in relative absorbed dose between two adjacent pixels in the target volume.
Combined standard uncertainty
Using the type A and type B standard uncertainties, the combined standard uncertainty was calculated as
Assuming a Gaussian distribution, the combined standard uncertainty corresponds to a confidence limit of about 68%. An expanded uncertainty, corresponding to an increased confidence interval, is obtained by applying a coverage factor k:
III. RESULTS
A. Treatment plan verification
An approximately linear dose response evaluated by means of R2 was found for absorbed doses up to 20 .999), respectively. The assumption of a linear dose response was thus justified for both measurements and a relative dose evaluation was undertaken. The latter measurement was used for comparison with the treatment planning system calculations.
The overall agreement between calculated and gel measured dose distributions in the isocenter plane was very good ͑Fig. 3͒. The 70% and 90% isodoses were mostly within 2 mm, with up to 3 mm disagreement at occasional points. Hot spots in the upper and lower part of the target region were evident on both gel-measured and calculated dose distributions. However, the relative dose according to the gel measurement was higher in these regions, with a maximum deviation of 11%.
For the PTV dose volume histograms ͓Fig. 4͑a͔͒, the agreement between calculated and measured data was again very good. The calculated mean relative dose to the PTV was 96.8Ϯ2.5% ͑1 SD͒, while the corresponding gel measured value was 98.6Ϯ2.2% ͑Table III͒. The maximum and minimum relative absorbed doses obtained through measurement and calculation are also presented in Table III . For the PTV, the absorbed dose interval between maximum and minimum dose was larger for the gel measured than for the calculated dose distribution. This can also be observed in the dose volume histograms; according to the DVH obtained from measured data, approximately 2% of the PTV received a higher dose than the TPS calculated maximum dose.
The DVH for the OAR indicate a somewhat larger deviation between measured and calculated data in this volume, compared to the PTV ͓Fig. 4͑b͔͒. The calculated mean relative absorbed dose to the OAR was 34.4Ϯ0.9%, while the corresponding gel measured value was 32.7Ϯ0.7% ͑Table III͒.
The gamma pass criterion chosen was 3 mm distance to agreement and Ϯ3% dose difference, consistent with previously used acceptance levels. 5 This criterion was passed for 94% of the points in the target region ͑Fig. 5͒. Except for a small number of scattered points near the edges, the disagreement was limited to the hot spot regions. 
B. Evaluation of standard uncertainty in relative absorbed dose measurements
The maximum relative T2 difference in the homogenous phantom used for evaluation of RF field non-uniformity was 3% ͑Table IV͒. Also listed in Table IV are the estimated uncertainties from the other sources discussed in Sec. II E.
For the calculation of type B standard uncertainties cϭ2 was used. The resulting combined standard uncertainty was 2.5% for the determination of relative dose, and 3.6% in the case of dose distribution comparisons. An expanded uncertainty, approximately corresponding to a 95% confidence level, was calculated by applying a coverage factor kϭ2. Thus for the comparison of dose distributions, the expanded uncertainty was found to be 7.1%.
IV. DISCUSSION
This is to our knowledge the first clinical application measurement reported using MAGIC-type polymer gel. The manufacturing and handling of MAGIC-type gel is much simplified compared to BANG-type gel since the demand for an oxygen-free environment is eliminated. As a consequence the mixing procedure is also much faster. Furthermore, since the container material does not need to be nonpermeable to oxygen, manufacturing and use of complex phantoms will be much facilitated. Provided an easily accessible and fast imaging system, the total experimental time needed can be significantly reduced. This is a very important step towards making gel dosimetry a standard tool for verification of three dimensional dose distributions.
The isocenter-plane comparison between calculated and measured data showed that for 98% of the points in the target region the difference was well within the estimated standard uncertainty. The only significant difference between the compared distributions in the target region was the higher measured dose in the hot spots in the upper and lower parts. This is further confirmed by the quantitative gamma evaluation. These discrepancies can be attributed to sub optimal scatter kernels used in the TPS dose calculations. Local peaks of overdosage of 10-20 % compared to the Helios TPS calculations have been observed near steep dose gradients using film measurements. 23 The reason for these deviations was found to be broadening of the pencil beam scatter kernels derived through deconvolution of configurational beam profile data. The diameter of the ion chamber used for measurement of the beam data causes broadening of the beam penumbra, which in turn translates to broadening of the pencil beam scatter kernels. The demands on kernels used for IMRT absorbed dose calculations are higher than on those used for conventional static beam calculations. Thus, kernels derived in this way may not be appropriate for use with IMRT. 23 Criteria for the optimization of IMRT treatment plans are often based on DVH constraints. The DVH is also an important tool in the evaluation of calculated dose distributions. Gel dosimetry is a unique system in the sense that DVHs FIG. 5 . Gamma distribution for the comparison of gel-measured and calculated dose distributions in the isocenter plane ͑target region in gray͒. Pixels for which the gamma criteria ͑3 mm spatial/3% dose deviation͒ failed are white. covering complete volumes of interest can be obtained through one single measurement. The small deviations in the dose volume histograms seen in this study may partly be attributed to difficulties in a correct determination of the background value. A too high background value will lead to an underestimation of the relative dose for doses smaller than the normalization dose, and an overestimation for doses larger than the normalization dose. The effect will be most pronounced in low dose regions, i.e., in this case the organ at risk. In the present case a 10% decrease of the background value would lead to approximately 3% increase of the mean dose to the OAR. This effect may partly explain the difference between measured and calculated mean doses observed in this study. The background value was taken from an unirradiated part of the phantom. For other applications, where the irradiated volume is not spatially restricted, other methods for background correction might be needed. 24, 25 A way to improve background subtraction further would be to employ a second gel filled phantom as a reference. The phantom should be identical to the investigated one and subject to the same handling, except it would not be irradiated.
The slope and intercept reported by Fong for a MAGIC gel with 6% methacrylic acid measured at 85 MHz was 0.567 s Ϫ1 Gy Ϫ1 and 4.07 s Ϫ1 , respectively. Both values are considerably higher than in this study. However, even small differences in temperature during MRI scanning has been shown to affect the measured T2 value. 26 Furthermore, different gel compositions as well as magnetic field strengths were used. Thus, the values are not directly comparable. The slope-to-intercept ratios are approximately the same in both studies.
Changes both in slope and intercept of the R2 versus dose curve with time after irradiation, as reported in this study, has also been observed for BANG-type gel. 13, 27, 28 De Deene et al. suggest that the variation in intercept is due to gelation of the gelatin, which continues for about 1 month. Since this process is controlled by gelatin, all gelatin based dosimetry gels can be expected show similar behavior. The changes in intercept and slope are of course important for an understanding of the gels response to absorbed dose and temporal behavior. However, since relative dosimetry was employed in this study, the change in intercept and/or slope will not affect the resulting values, provided that no changes occur during imaging. The fact that a linear dose response curve was obtained at both scanning occassions implies that both measurements could have been used for relative evaluation.
The absolute value of T2 will affect the dose resolution of the dosimeter, 29 and the type A uncertainty most likely could be lowered if the pulse sequence was optimized for the measured range of T2 values. However, in case of dose distribution comparisons, the type A uncertainty has a minor effect on the total uncertainty. Instead, a very important contributor to the total uncertainty is the uncertainty related to image and data processing. Image matching may be improved by using fiducial markers that are visible on both CT and MRI. 15 However, the image matching accuracy is ultimately limited by the spatial resolution of the imaging system, i.e., the voxel size. If evaluation on mm level is of interest, as is the case considering for example IMRT, sub-mm imaging may be required. Imaging with sub-mm resolution has been reported using optical CT. 30 The difficulties related to background subtraction and normalization would be reduced if absolute calibration of the gels could be performed, in which case neither background subtraction nor normalization are needed. However, unsatisfactory results have been reported in studies where absolute calibration of the gel has been undertaken. 5, 6 Thus, in most studies relative measurements have been performed.
V. CONCLUSION
The MAGIC-type polymer gel used in this study was shown to be feasible for IMRT verification. Very good agreement between calculated and measured data was obtained for all evaluations performed. Discrepancies of up to 11% were found in hot spots the upper and lower parts of the PTV, which were explained by inadequate scatter kernels used in the TPS dose calculations. The increase in intercept observed between the imaging sessions was attributed to long-term gelation processes. The uncertainty related to image processing was found to be a very important factor when comparing dose distributions obtained using different methods. Improved image matching and absolute calibration of the gel are ways to improve the current technique.
Comparing the MAGIC-type gel used in this study with BANG-type gel, manufacturing and handling is greatly simplified. The demand for specialized equipment as well as the time needed for manufacturing is decreased. The feasibility of the system is thus much improved, which is important in order to implement gel dosimetry into the clinic. The introduction of this gel is most likely a large step on the way to make gel dosimetry a standard tool for 3D dosimetric verification.
